HLA-G was first found to be involved in immune tolerance by suppressing maternal immune responses to fetal tissues, and recent studies have suggested that HLA-G might represent a promising target for anti-cancer immunotherapies, since increased expression of HLA-G has been reported in several kinds of cancer [96]. This evidence concerns the gene HLA-G and cancer.